About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
LIFE Trial Rationale and Design: Sacubitril/Valsartan in Advanced Heart Failure with Reduced Ejection Fraction. Will It Improve NT-proBNP Levels?
By
American College of Cardiology
FEATURING
Christopher O'Connor
,
Eugene Braunwald
,
Douglas Mann
By
American College of Cardiology
FEATURING
Christopher O'Connor
,
Eugene Braunwald
,
Douglas Mann
304 views
September 18, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Medical College of Georgia - Augusta University
Cardiovascular Summit at Kiawah 2024
Thu, Jul 18, 2024
12:18
CCM® Therapy
HRS 2024: Cardiac Contractility Modulation - Don’t Wait!
Feat.
R. Kahwash
13:58
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
Feat.
J. Thomas Heywood
40:17
American College of Cardiology
Heart Failure with Preserved Ejection Fraction: Current Perspectives…
Feat.
S. Shah
06:23
CVRx | Barostim
ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…
Feat.
W. Abraham,
F. Arribas,
M. Zile
06:16
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT
Feat.
D. Yaranov
11:49
CVRx | Barostim
ESC 2023: Unmet needs and opportunities with device therapies of HFr…
Feat.
W. Abraham
12:21
CVRx | Barostim
Baroreflex Activation Therapy Overview of Clinical Data
Feat.
L. Tsao
28:03
Houston Methodist DeBakey Heart and Vascular Center
How to Detect and Treat Heart Failure with Preserved Ejection Fracti…
16:11
Jeffrey Weitz
Extended Anticoagulation for VTE
14:18
CCM® Therapy
The CCM Solution: How Does it Work and What Does it Do?
Feat.
N. Varma
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
19:30
American Heart & Vascular Institute
ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…
Feat.
B. Reddy
24:19
Ajith Nair
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy
Feat.
A. Nair
09:54
Mount Sinai
The ISCHEMIA Trial: Are There Differences in Primary and Secondary O…
Feat.
G. Stone
54:29
Terumo Interventional Systems
Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evalua…
Feat.
J. Spertus
10:42
CVRx | Barostim
Barostim Clinical Evidence
Feat.
L. Grazette
32:09
Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
Right Ventricular Failure: Diagnosis and Management
Feat.
A. Srivastava
09:40
Arun Kochar
'Heart Failure: Future perspectives
Feat.
A. Kochar
17:35
CVRx | Barostim
Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients H…
Feat.
M. Fudim,
R. Cole,
L. Grazette
35:35
CCM® Therapy
AHA 2020 - Heart Failure Classification for Appropriate Device Thera…
Feat.
W. Abraham,
N. Raval,
J. Singh
